Dr. Drobyski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Bone
Milwaukee, WI 53226Phone+1 414-805-6817Fax+1 414-456-6321
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1988 - 1990
University of RochesterFellowship, Hematology and Medical Oncology, 1987 - 1988- University of RochesterResidency, Internal Medicine, 1983 - 1986
University of Rochester School of Medicine and DentistryClass of 1983
Certifications & Licensure
WI State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Tocilizumab for Chronic Graft-versus-Host Disease Treatment Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 95 citationsEmergent autoimmunity in graft-versus-host disease.Elizabeth Tivol, Richard A. Komorowski, William R. Drobyski
Blood. 2005-06-15 - 297 citationsIncreasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He
Biology of Blood and Marrow Transplantation. 2015-02-01 - 6 citationsSingle-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.Clint Piper, Emma Hainstock, Cheng Yin-Yuan, Yao Chen, Achia Khatun
Blood Advances. 2022-05-10
Abstracts/Posters
- Single Cell Immune Profiling of Colitogenic T Cells during Acute Graft Versus Host Disease Reveals Two Novel Transcriptionally Distinct CD4+ GM-CSF+ LineagesWilliam R. Drobyski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host DiseaseWilliam R. Drobyski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
